Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergy Testing of FDA-Approved Drugs Identifies Potent Drug Combinations against Trypanosoma cruzi
Authors
Keywords
-
Journal
PLoS Neglected Tropical Diseases
Volume 8, Issue 7, Pages e2977
Publisher
Public Library of Science (PLoS)
Online
2014-07-18
DOI
10.1371/journal.pntd.0002977
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Global economic burden of Chagas disease: a computational simulation model
- (2013) Bruce Y Lee et al. LANCET INFECTIOUS DISEASES
- Use of clomipramine as chemotherapy of the chronic phase of Chagas disease
- (2013) ROMINA FAURO et al. PARASITOLOGY
- Benznidazole and Posaconazole in Experimental Chagas Disease: Positive Interaction in Concomitant and Sequential Treatments
- (2013) Lívia de Figueiredo Diniz et al. PLoS Neglected Tropical Diseases
- Pharmacological Characterization, Structural Studies, andIn VivoActivities of Anti-Chagas Disease Lead Compounds Derived from Tipifarnib
- (2012) Frederick S. Buckner et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Effects of amiodarone and posaconazole on the growth and ultrastructure of Trypanosoma cruzi
- (2012) Phercyles Veiga-Santos et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Pharmacology of DB844, an Orally Active aza Analogue of Pafuramidine, in a Monkey Model of Second Stage Human African Trypanosomiasis
- (2012) John K. Thuita et al. PLoS Neglected Tropical Diseases
- Activity In Vivo of Anti-Trypanosoma cruzi Compounds Selected from a High Throughput Screening
- (2011) Grasiella Andriani et al. PLoS Neglected Tropical Diseases
- Antileishmanial and Antitrypanosomal Activities of the 8-Aminoquinoline Tafenoquine
- (2010) V. Yardley et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Image-Based High-Throughput Drug Screening Targeting the Intracellular Stage of Trypanosoma cruzi, the Agent of Chagas' Disease
- (2010) J. C. Engel et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Anti-leishmanial and anti-trypanosomal activities of 1,4-dihydropyridines: In vitro evaluation and structure–activity relationship study
- (2010) Juliana Q. Reimão et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Chagas disease: pushing through the pipeline
- (2010) Julie Clayton NATURE
- Chagas disease: a new worldwide challenge
- (2010) José Rodrigues Coura et al. NATURE
- Rational Modification of a Candidate Cancer Drug for Use Against Chagas Disease
- (2009) James M. Kraus et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ergosterol biosynthesis and drug development for Chagas disease
- (2009) Julio A Urbina MEMORIAS DO INSTITUTO OSWALDO CRUZ
- New, Improved Treatments for Chagas Disease: From the R&D Pipeline to the Patients
- (2009) Isabela Ribeiro et al. PLoS Neglected Tropical Diseases
- Suramin and minocycline treatment of experimental African trypanososmiasis at an early stage of parasite brain invasion
- (2008) Daniel Ndem Amin et al. ACTA TROPICA
- Chemical and genetic validation of dihydrofolate reductase–thymidylate synthase as a drug target in African trypanosomes
- (2008) Natasha Sienkiewicz et al. MOLECULAR MICROBIOLOGY
- Chemotherapy of chronic indeterminate Chagas disease: a novel approach to treatment
- (2008) Paola Carolina Bazán et al. PARASITOLOGY RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now